Harbor Capital Advisors, Inc. Cabaletta Bio, Inc. Transaction History

Harbor Capital Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 28, 2022	BUY	$0.63 - $2.05 $19,317 - $62,859	30,663 Added 27.14%	143,629 $93,000
Q2 2022 Jul 26, 2022	SELL	$0.99 - $2.11 $6,285 - $13,396	-6,349 Reduced 5.32%	112,966 $120,000
Q1 2022 Apr 28, 2022	SELL	$1.68 - $3.92 $39,432 - $92,010	-23,472 Reduced 16.44%	119,315 $242,000
Q4 2021 Feb 04, 2022	BUY	$3.36 - $14.64 $479,764 - $2.09 Million	142,787 New	142,787 $541,000

126

47.9M

202K

110K

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $76M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.